Q32 Bio Inc.
QTTB
$3.65
$0.247.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1,169.64% | 5.66% | |||
| Gross Profit | -1,169.64% | -5.66% | |||
| SG&A Expenses | 0.30% | -21.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.38% | -18.87% | |||
| Operating Income | 17.38% | 18.87% | |||
| Income Before Tax | 22.13% | 13.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.13% | 13.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.13% | 13.98% | |||
| EBIT | 17.38% | 18.87% | |||
| EBITDA | 17.56% | 18.82% | |||
| EPS Basic | 22.41% | 13.99% | |||
| Normalized Basic EPS | 22.40% | 5.19% | |||
| EPS Diluted | 22.62% | 13.75% | |||
| Normalized Diluted EPS | 22.40% | 5.19% | |||
| Average Basic Shares Outstanding | 0.35% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||